MECHANISMS OF ACOUSTIC DISTORTION GENERATION
声学失真的产生机制
基本信息
- 批准号:2126682
- 负责人:
- 金额:$ 9.91万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1992
- 资助国家:美国
- 起止时间:1992-09-30 至 1998-11-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The distortion-product otacoustic emission (DPOAE) at 2f1-f2 shows great
potential as a powerful tool for the clinical diagnosis of sensorineural
hearing losses. Previous studies of this emission in rabbits and
rodents, by the PI and others, strongly support a "black-box" model in
which the 2f1-f2 DPOAE is produced by two discrete cochlear sources, one
dominant at high stimulus levels (above 60-70 dB SPL), and the other
dominant at lower levels. However, the nature of the two sources, and
their relationship to the hearing process, are obscure. A primary aim
of the proposed project is to investigate the locations of, and the
physiological mechanisms underlying, the two DPOAE sources, in guinea
pigs, in order to gather the knowledge required to develop the PI's
model, by incorporating known cochlear processes. Thus, suppression,
interference, and localized noise-trauma paradigms will be used to test
the hypothesis that the two DPOAE sources are located at different sites
along the cochlear partition, relative to the primary-tone region.
Additionally, DPOAEs and other otacoustic-emission types will be recorded
concurrently with electrophysiological measures of cochlear function
during manipulations thought to specifically impair the action of the
cochlear amplifier. These experiments will enhance our understanding of
the generation of DPOAEs and other emission phenomena and, specifically,
will help to clarify the relationship[ of otacoustic emissions to the
cochlear amplifier, thought to be based in outer hair-cell
electromotility.
Because of major differences of the properties of otacoustic emissions
between small mammals and humans, it is not clear that the model of
discrete low- and high-level DPOE sources, developed on the basis of data
from small mammals, can be generalized to humans. A primary aim of the
proposed project is to test the hypothesis that there are discrete low-
and high-level DPOAE sources in human ears, by utilizing techniques,
similar to those employed to identify the two DPOAE sources in small
mammals, that specifically test predictions of the PI's model. These
techniques include detailed measurement of DPOAE-amplitude and phase
variations upon systematic changes of stimulus parameters and measurement
of the effect of aspirin ingestion on DPOAEs elicited by low- and high-
level stimuli. In addition, the relationship of DPOAEs and the other
otacoustic-emission phenomena will be studied by concurrent measurement
of DPOAEs and the other emission types, in guinea pigs during a variety
of cochlear manipulations, and in humans during aspirin ingestion. These
experiments will improve our understanding of the relationship of the
various otacoustic-emission phenomena to each other, and to the hearing
process. This knowledge will aid in the design, experimental testing,
and interpretation of results of clinical tests utilizing otacoustic
emissions.
畸变产物耳声发射(DPOAE)在2f 1-f2处表现出很大的
作为临床诊断感音神经性疾病的有力工具
听力损失 以前在兔子和
啮齿类动物,由PI和其他人,强烈支持一个“黑箱”模型,
其中2f 1-f2 DPOAE由两个离散的耳蜗源产生,一个
在高刺激水平(高于60-70 dB SPL)下占主导地位,
在较低水平上占主导地位。 然而,这两个来源的性质,
他们与听证会的关系是模糊的。 主要目标
的建议项目是调查的位置,和
豚鼠两种DPOAE源的生理机制
猪,以收集开发PI所需的知识
模型,通过结合已知的耳蜗过程。 因此,镇压,
干扰和局部噪声创伤范例将用于测试
两个DPOAE源位于不同地点的假设
沿着耳蜗分区,相对于主音调区域。
此外,还将记录DPOAE和其他耳声发射类型
同时进行耳蜗功能的电生理测量
在被认为是专门损害的作用,
耳蜗放大器 这些实验将增强我们对
DPOAE和其他发射现象的产生,具体地,
将有助于澄清耳声发射与
耳蜗放大器,被认为是基于外毛细胞
电动性
由于耳声发射的性质存在很大差异,
在小型哺乳动物和人类之间,目前尚不清楚
离散的低和高级别DPOE源,根据数据开发
从小型哺乳动物,可以推广到人类。 一个主要目标的
建议的项目是测试假设,有离散低-
和人耳中的高水平DPOAE源,
类似于那些用来确定两个DPOAE源在小
哺乳动物,专门测试PI模型的预测。 这些
技术包括详细测量DPOAE振幅和相位
刺激参数和测量的系统变化的变化
阿司匹林摄入对低剂量和高剂量DPOAE的影响
水平刺激。 此外,还讨论了DPOAEs与其他
耳声发射现象将通过同步测量进行研究
DPOAE和其他发射类型,在豚鼠在各种
耳蜗操作,以及人类服用阿司匹林期间。 这些
实验将提高我们的理解的关系,
各种耳声发射现象相互影响,
过程 这些知识将有助于设计,实验测试,
并利用耳声技术解释临床测试结果
排放
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARTIN L WHITEHEAD其他文献
MARTIN L WHITEHEAD的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARTIN L WHITEHEAD', 18)}}的其他基金
MECHANISM OF ACOUSTIC DISTORTION PRODUCT GENERATION
声学失真产物的产生机制
- 批准号:
3509659 - 财政年份:1992
- 资助金额:
$ 9.91万 - 项目类别:
相似国自然基金
Aspirin调控AKT/Foxo3a/BIM通路延缓吡咯替尼耐药作用机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:0.0 万元
- 项目类别:省市级项目
Aspirin与自噬通路及核转录因子FoxG1在听觉系统退行性变中的协同调控机制研究
- 批准号:81800915
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
Aspirin联合牙周膜干细胞再生全脱位牙牙周组织机制研究
- 批准号:81760190
- 批准年份:2017
- 资助金额:32.0 万元
- 项目类别:地区科学基金项目
可注射温敏型水凝胶缓释Aspirin碳点和EPO促牙周组织再生的研究
- 批准号:81600879
- 批准年份:2016
- 资助金额:17.0 万元
- 项目类别:青年科学基金项目
Aspirin协同IFN-α抑制肝癌转移复发的作用及机制研究
- 批准号:30972889
- 批准年份:2009
- 资助金额:31.0 万元
- 项目类别:面上项目
胃癌microRNA特异表达与靶基因调控及Aspirin的作用
- 批准号:30873099
- 批准年份:2008
- 资助金额:35.0 万元
- 项目类别:面上项目
相似海外基金
Postpartum low-dose aspirin to augment vascular recovery following a hypertensive disorder of pregnancy
产后小剂量阿司匹林可促进妊娠高血压疾病后的血管恢复
- 批准号:
10644089 - 财政年份:2023
- 资助金额:
$ 9.91万 - 项目类别:
Aspirin, Lp(a) and Primary Prevention of Cardiovascular Events
阿司匹林、Lp(a) 和心血管事件的一级预防
- 批准号:
10720757 - 财政年份:2023
- 资助金额:
$ 9.91万 - 项目类别:
Early Double Low-Dose Aspirin to Reduce Preeclampsia and Miscarriage: a Global Approach RCT
早期双倍低剂量阿司匹林减少先兆子痫和流产:全球方法随机对照试验
- 批准号:
10711793 - 财政年份:2023
- 资助金额:
$ 9.91万 - 项目类别:
Aspirin for Primary Prevention of Cardiovascular Disease in Patients with Elevated Lipoprotein(a)
阿司匹林用于脂蛋白升高患者心血管疾病的一级预防(a)
- 批准号:
10739016 - 财政年份:2023
- 资助金额:
$ 9.91万 - 项目类别:
The PARTUM (Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity) Trial
PARTUM(产后阿司匹林减少血栓栓塞过度发病率)试验
- 批准号:
498295 - 财政年份:2023
- 资助金额:
$ 9.91万 - 项目类别:
Operating Grants
Health Outcomes of Discontinuing Aspirin in Older Adults with Alzheimer's Disease and Related Dementias
患有阿尔茨海默病和相关痴呆症的老年人停用阿司匹林的健康结果
- 批准号:
10662129 - 财政年份:2023
- 资助金额:
$ 9.91万 - 项目类别:
A study on the use of aspirin mini tablets for children with Kawasaki disease for the practical application of mini tablets
阿司匹林迷你片在川崎病患儿中的应用研究
- 批准号:
23K16462 - 财政年份:2023
- 资助金额:
$ 9.91万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Is Aspirin a Cost-Effective Thromboprophylaxis Alternative for Orthopaedic Trauma Patients?
阿司匹林是骨科创伤患者经济有效的血栓预防替代方案吗?
- 批准号:
10784156 - 财政年份:2023
- 资助金额:
$ 9.91万 - 项目类别:
Aspirin and severe maternal morbidity and mortality and adverse pregnancy outcomes
阿司匹林与严重孕产妇发病率和死亡率以及不良妊娠结局
- 批准号:
469014 - 财政年份:2022
- 资助金额:
$ 9.91万 - 项目类别:
Operating Grants
Effects of inflammaging on intestinal epithelial cells and aspirin chemoprevention.
炎症对肠上皮细胞的影响和阿司匹林化学预防。
- 批准号:
10152090 - 财政年份:2021
- 资助金额:
$ 9.91万 - 项目类别: